When applying a 5% PD-L1 tumor-nest cut-off, 70% of samples segregated to the high PD-L1 group, with CD8, Granzyme B, and CD68 significantly higher in those samples (P < 0.05). The gene discussed is CD8A; the disease is neoplasm.